View in EDS

Cemiplimab in Locally Advanced or Metastatic Secondary Angiosarcomas (CEMangio): A Phase II Clinical Trial and Biomarker Analyses.

Saved in:
Bibliographic Details
Title: Cemiplimab in Locally Advanced or Metastatic Secondary Angiosarcomas (CEMangio): A Phase II Clinical Trial and Biomarker Analyses.
Authors: van Ravensteijn SG; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands., de Haan JJ; Department of Medical Oncology, University Medical Center Groningen, Groningen, the Netherlands., Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands., Nederkoorn MJL; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands., Hillebrandt-Roeffen MHS; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands., Gorris MAJ; Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, the Netherlands., de Bitter TJJ; Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands., Boleij A; Department of Pathology, Radboud University Medical Center, Nijmegen, the Netherlands., Gusinac A; Department of Pathology, Radboud University Medical Center, Nijmegen, the Netherlands., Ederveen THA; Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, the Netherlands., Flucke UE; Department of Pathology, Radboud University Medical Center, Nijmegen, the Netherlands., Bonenkamp JJ; Department of Surgery, Radboud University Medical Center, Nijmegen, the Netherlands., Speetjens FM; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands., Kaal SEJ; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands., Smits M; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands., Bol KF; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.; Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, the Netherlands., van Herpen CML; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands., Versleijen-Jonkers YMH; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands., Desar IME; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.
Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2025 Sep 02; Vol. 31 (17), pp. 3678-3691.
Publication Type: Journal Article; Clinical Trial, Phase II; Multicenter Study
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40632032
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Cemiplimab in Locally Advanced or Metastatic Secondary Angiosarcomas (CEMangio): A Phase II Clinical Trial and Biomarker Analyses.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22van+Ravensteijn+SG%22">van Ravensteijn SG</searchLink>; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.<br /><searchLink fieldCode="AU" term="%22de+Haan+JJ%22">de Haan JJ</searchLink>; Department of Medical Oncology, University Medical Center Groningen, Groningen, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Gelderblom+H%22">Gelderblom H</searchLink>; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Nederkoorn+MJL%22">Nederkoorn MJL</searchLink>; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Hillebrandt-Roeffen+MHS%22">Hillebrandt-Roeffen MHS</searchLink>; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Gorris+MAJ%22">Gorris MAJ</searchLink>; Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, the Netherlands.<br /><searchLink fieldCode="AU" term="%22de+Bitter+TJJ%22">de Bitter TJJ</searchLink>; Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Boleij+A%22">Boleij A</searchLink>; Department of Pathology, Radboud University Medical Center, Nijmegen, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Gusinac+A%22">Gusinac A</searchLink>; Department of Pathology, Radboud University Medical Center, Nijmegen, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Ederveen+THA%22">Ederveen THA</searchLink>; Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Flucke+UE%22">Flucke UE</searchLink>; Department of Pathology, Radboud University Medical Center, Nijmegen, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Bonenkamp+JJ%22">Bonenkamp JJ</searchLink>; Department of Surgery, Radboud University Medical Center, Nijmegen, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Speetjens+FM%22">Speetjens FM</searchLink>; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Kaal+SEJ%22">Kaal SEJ</searchLink>; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Smits+M%22">Smits M</searchLink>; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Bol+KF%22">Bol KF</searchLink>; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.; Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, the Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Herpen+CML%22">van Herpen CML</searchLink>; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Versleijen-Jonkers+YMH%22">Versleijen-Jonkers YMH</searchLink>; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Desar+IME%22">Desar IME</searchLink>; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229502500%22">Clinical cancer research : an official journal of the American Association for Cancer Research</searchLink> [Clin Cancer Res] 2025 Sep 02; Vol. 31 (17), pp. 3678-3691.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Clinical Trial, Phase II; Multicenter Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%22">American Association for Cancer Research </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9502500 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1557-3265 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210780432%22">10780432 </searchLink><i>NLM ISO Abbreviation: </i>Clin Cancer Res <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40632032
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1158/1078-0432.CCR-25-0311
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 3678
    Titles:
      – TitleFull: Cemiplimab in Locally Advanced or Metastatic Secondary Angiosarcomas (CEMangio): A Phase II Clinical Trial and Biomarker Analyses.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: van Ravensteijn SG
      – PersonEntity:
          Name:
            NameFull: de Haan JJ
      – PersonEntity:
          Name:
            NameFull: Gelderblom H
      – PersonEntity:
          Name:
            NameFull: Nederkoorn MJL
      – PersonEntity:
          Name:
            NameFull: Hillebrandt-Roeffen MHS
      – PersonEntity:
          Name:
            NameFull: Gorris MAJ
      – PersonEntity:
          Name:
            NameFull: de Bitter TJJ
      – PersonEntity:
          Name:
            NameFull: Boleij A
      – PersonEntity:
          Name:
            NameFull: Gusinac A
      – PersonEntity:
          Name:
            NameFull: Ederveen THA
      – PersonEntity:
          Name:
            NameFull: Flucke UE
      – PersonEntity:
          Name:
            NameFull: Bonenkamp JJ
      – PersonEntity:
          Name:
            NameFull: Speetjens FM
      – PersonEntity:
          Name:
            NameFull: Kaal SEJ
      – PersonEntity:
          Name:
            NameFull: Smits M
      – PersonEntity:
          Name:
            NameFull: Bol KF
      – PersonEntity:
          Name:
            NameFull: van Herpen CML
      – PersonEntity:
          Name:
            NameFull: Versleijen-Jonkers YMH
      – PersonEntity:
          Name:
            NameFull: Desar IME
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 09
              Text: 2025 Sep 02
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1557-3265
          Numbering:
            – Type: volume
              Value: 31
            – Type: issue
              Value: 17
          Titles:
            – TitleFull: Clinical cancer research : an official journal of the American Association for Cancer Research
              Type: main
ResultId 1